share_log

Some May Be Optimistic About Henan Hengxing Science & TechnologyLtd's (SZSE:002132) Earnings

Some May Be Optimistic About Henan Hengxing Science & TechnologyLtd's (SZSE:002132) Earnings

有些人可能對河南恒興科技股份有限公司(深圳證券交易所:002132)的收益持樂觀態度
Simply Wall St ·  05/03 19:06

Henan Hengxing Science & Technology Co.,Ltd.'s (SZSE:002132) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed strength. We think that investors might be looking at some positive factors beyond the earnings numbers.

河南恒興科技股份有限公司, Ltd. 's(SZSE:002132)最近的疲軟利潤數字似乎並沒有讓股東感到擔憂,因爲股價表現出強勁的勢頭。我們認爲,除了收益數字外,投資者可能會考慮一些積極因素。

earnings-and-revenue-history
SZSE:002132 Earnings and Revenue History May 3rd 2024
SZSE: 002132 2024 年 5 月 3 日的收益和收入歷史記錄

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

For anyone who wants to understand Henan Hengxing Science & TechnologyLtd's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by CN¥48m due to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. If Henan Hengxing Science & TechnologyLtd doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.

對於任何想了解法定數字之外的河南恒興科技有限公司利潤的人來說,值得注意的是,在過去的十二個月中,由於不尋常的項目,法定利潤減少了4,800萬元人民幣。看到不尋常的項目使公司利潤付出代價從來都不是一件好事,但從好的方面來看,情況可能遲早會好轉。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。而且,畢竟,這正是會計術語的含義。如果河南恒興科技有限公司不看到這些不尋常的支出重演,那麼在其他條件相同的情況下,我們預計其利潤將在來年增加。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Henan Hengxing Science & TechnologyLtd.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對河南恒興科技股份有限公司的資產負債表分析

Our Take On Henan Hengxing Science & TechnologyLtd's Profit Performance

我們對河南恒興科技股份有限公司盈利表現的看法

Unusual items (expenses) detracted from Henan Hengxing Science & TechnologyLtd's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Henan Hengxing Science & TechnologyLtd's statutory profit actually understates its earnings potential! On the other hand, its EPS actually shrunk in the last twelve months. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So while earnings quality is important, it's equally important to consider the risks facing Henan Hengxing Science & TechnologyLtd at this point in time. For example, we've found that Henan Hengxing Science & TechnologyLtd has 4 warning signs (1 can't be ignored!) that deserve your attention before going any further with your analysis.

不尋常的項目(支出)減少了河南恒興科技股份有限公司去年的收益,但明年我們可能會看到改善。基於這一觀察,我們認爲河南恒興科技股份有限公司的法定利潤實際上可能低估了其盈利潛力!另一方面,其每股收益實際上在過去十二個月中萎縮了。當然,我們只是在分析其收益時才浮出水面;人們還可以考慮利潤率、預測增長和投資回報率等因素。因此,儘管收益質量很重要,但考慮河南恒興科技股份有限公司目前面臨的風險同樣重要。例如,我們發現河南恒興科技有限公司有 4 個警告標誌(1 個不容忽視!)在進行進一步分析之前,這值得你注意。

Today we've zoomed in on a single data point to better understand the nature of Henan Hengxing Science & TechnologyLtd's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

今天,我們放大了單個數據點,以更好地了解河南恒興科技有限公司利潤的性質。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。有些人認爲高股本回報率是優質業務的好兆頭。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論